Presentation
SAT0463 SECUKINUMAB PROVIDES SUSTAINED REDUCTION IN FATIGUE IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS THROUGH 3 YEARS: LONG-TERM DATA FROM THE FUTURE 1 AND FUTURE 2 STUDIES. The European League against Rheumatism (EULAR) Annual European Congress of Rheumatology, Madrid, June 2017
The European League against Rheumatism (EULAR) Annual European Congress of Rheumatology
(2017)
Disciplines
Publication Date
June, 2017
Citation Information
L Gossec, TK Kvien, Philip Mease and et.al.. "SAT0463 SECUKINUMAB PROVIDES SUSTAINED REDUCTION IN FATIGUE IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS THROUGH 3 YEARS: LONG-TERM DATA FROM THE FUTURE 1 AND FUTURE 2 STUDIES. The European League against Rheumatism (EULAR) Annual European Congress of Rheumatology, Madrid, June 2017" The European League against Rheumatism (EULAR) Annual European Congress of Rheumatology (2017) Available at: http://works.bepress.com/philip-mease/247/